{"id":9146,"date":"2020-04-28T10:15:21","date_gmt":"2020-04-28T08:15:21","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=9146"},"modified":"2024-11-07T14:12:21","modified_gmt":"2024-11-07T13:12:21","slug":"prof-dr-benjamin-heidrich","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-benjamin-heidrich\/","title":{"rendered":"Prof. Dr. Benjamin Heidrich"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Benjamin Heidrich participates in RESIST research project B11.<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>
\n
\n
\n

Our research focus in RESIST is the susceptibility to cholangitis and individual treatment approaches in primary sclerosing cholangitis (PSC) before and after liver transplantation (LTX) (SusTreat-PSC). The biliary tract was considered to be a sterile niche. However, we and others could show that even in healthy individuals there is an existing biliary microbiota. Patients with PSC are at high risk to develop bacterial cholangitis often chronic recurrent cholangitis leading to chronic liver failure and the need of liver transplantation.<\/p>\n

Within RESIST we are interest to define the bacteria and their specific mechanisms being involved in the development of bacterial cholangitis. With the knowledge we plan to improve the recommendations regarding antibiotic therapies, define new treatment approaches for targeted therapies and implement screening methods for patients at risk of bacterial cholangitis.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/i><\/span>Contact<\/span><\/a><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Heidrich about his scientific work<\/h1><\/div>